Cargando…
The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
Positron emission tomography (PET) using (18)fluoro-2-deoxyglucose (FDG) has become a standard clinical tool for staging and response assessment in aggressive lymphomas. The use of PET scans in clinical trials is still under exploration, however. In this review, we examine current data regarding PET...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264252/ https://www.ncbi.nlm.nih.gov/pubmed/25608713 http://dx.doi.org/10.1186/s40644-014-0034-9 |